Key result
Provided text contains no clinical data regarding thrombotic events in newborns.
Why the study?
Thrombotic events are relatively rare in neonates, and treatment strategies differ in dosage and duration from older children.
LMWH is an effective and well-tolerated treatment for neonatal thrombotic events, leading to at least partial regression in 84% of cases without significant complications.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zapletal et al. (2024) studied this question. The provided text is a GDPR privacy policy and consent form from Solen, s.r.o., and does not contain any clinical trial data regarding thrombotic events in newborns.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: